Publicacións nas que colabora con Francisca Lago Paz (46)

2017

  1. Leptin in the interplay of inflammation, metabolism and immune system disorders

    Nature Reviews Rheumatology, Vol. 13, Núm. 2, pp. 100-109

2015

  1. IL-36α: A novel cytokine involved in the catabolic and inflammatory response in chondrocytes

    Scientific Reports, Vol. 5

  2. New drugs from ancient natural foods. Oleocanthal, the natural occurring spicy compound of olive oil: A brief history

    Drug Discovery Today

  3. The potential of lipocalin-2/NGAL as biomarker for inflammatory and metabolic diseases

    Biomarkers, Vol. 20, Núm. 8, pp. 565-571

2014

  1. Adipokines as drug targets in joint and bone disease

    Drug Discovery Today, Vol. 19, Núm. 3, pp. 241-258

  2. Adiponectin and leptin: New targets in inflammation

    Basic and Clinical Pharmacology and Toxicology, Vol. 114, Núm. 1, pp. 97-102

  3. Bone metabolism and adipokines: Are there perspectives for bone diseases drug discovery?

    Expert Opinion on Drug Discovery, Vol. 9, Núm. 8, pp. 945-957

  4. Differential expression of adipokines in infrapatellar fat pad (IPFP) and synovium of osteoarthritis patients and healthy individuals

    Annals of the Rheumatic Diseases

  5. Endogenous cannabinoid anandamide impairs cell growth and induces apoptosis in chondrocytes

    Journal of Orthopaedic Research, Vol. 32, Núm. 9, pp. 1137-1146

  6. NUCB2/nesfatin-1: A new adipokine expressed in human and murine chondrocytes with pro-inflammatory properties, an in vitro study

    Journal of Orthopaedic Research, Vol. 32, Núm. 5, pp. 653-660

2013

  1. Adipokines, molecular players at the crossroad between inflammation and oxidative stress: Role in arthropathies

    Studies on Arthritis and Joint Disorders (Springer New York), pp. 67-88

  2. Adipokines: Novel players in rheumatic diseases

    Discovery Medicine, Vol. 15, Núm. 81, pp. 73-83

  3. Expression and modulation of adipolin/C1qdc2: A novel adipokine in human and murine ATDC-5 chondrocyte cell line

    Annals of the Rheumatic Diseases

  4. Leptin in joint and bone diseases: New insights

    Current Medicinal Chemistry, Vol. 20, Núm. 27, pp. 3416-3425

  5. Nitric oxide boosts TLR-4 mediated lipocalin 2 expression in chondrocytes

    Journal of Orthopaedic Research, Vol. 31, Núm. 7, pp. 1046-1052

  6. Oleocanthal inhibits proliferation and MIP-1α expression in human multiple myeloma cells

    Current Medicinal Chemistry, Vol. 20, Núm. 19, pp. 2467-2475

2012

  1. Adipokines as biomarkers of rheumatic diseases

    Drugs of the Future, Vol. 37, Núm. 8, pp. 591-597

  2. Adiponectin and Leptin Induce VCAM-1 Expression in Human and Murine Chondrocytes

    PLoS ONE, Vol. 7, Núm. 12

  3. Further evidence for the anti-inflammatory activity of oleocanthal: Inhibition of MIP-1α and IL-6 in J774 macrophages and in ATDC5 chondrocytes

    Life Sciences, Vol. 91, Núm. 23-24, pp. 1229-1235

2011

  1. Adipokines: Biofactors from white adipose tissue. A complex hub among inflammation, metabolism, and immunity

    BioFactors, Vol. 37, Núm. 6, pp. 413-420